Home > PE Ratio > INDOCO REMEDIES

INDOCO REMEDIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of INDOCO REMEDIES is -161.00.

Share Price ₹254.3Feb 01,2025
Market Cap ₹2,344.2 Cr
Earnings-TTM₹-14.6 CrTTM-Consolidated Results
Price/Earnings-161.00xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of INDOCO REMEDIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of INDOCO REMEDIES is calculated as :

Current Market Cap [ ₹2,344.2 Cr] as on Feb 01,2025

(/) Earnings [ ₹-14.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ -161.00x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for INDOCO REMEDIES , the investors are currently willing to pay -161.00 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDOCO REMEDIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of INDOCO REMEDIES over the last five years.

Historical PE (Price/Earnings) ratio chart of INDOCO REMEDIES


PE Ratio Performance Analysis for INDOCO REMEDIES

- INDOCO REMEDIES 's latest p/e ratio is -161.00x.

- INDOCO REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 36.57x.

- INDOCO REMEDIES 's operated at median p/e ratio of 28.57x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, INDOCO REMEDIES 's p/e ratio peaked in Mar2020 at 79.99x.

- INDOCO REMEDIES 's p/e ratio hit its five-year low in Mar2023 of 21.09x.


How does INDOCO REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
INDOCO REMEDIES -14.56-161.002,344.2
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0036.40418,132.0
CIPLA LTD5,000.4323.22116,123.0
DR REDDYS LABORATORIES LTD5,428.6018.53100,573.0
ZYDUS LIFESCIENCES LTD4,298.9022.7997,966.9
DIVIS LABORATORIES LTD1,836.0081.29149,254.0
MANKIND PHARMA LTD2,050.7349.91102,348.0
TORRENT PHARMACEUTICALS LTD1,862.0058.26108,477.0
LUPIN LTD2,651.9435.3893,813.7
AUROBINDO PHARMA LTD3,598.8318.4566,385.6
ABBOTT INDIA LTD1,284.6642.8655,059.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDOCO REMEDIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -161.00x
Max industry PE 81.29x
Median industry PE 35.38x
Average industry PE 20.55x



You may also like the below Video Courses